Adverse Drug Reactions (ADRs) pose significant risks to public health, making effective monitoring and reporting crucial components of any pharmaceutical regulatory framework. In Indonesia, the Indonesian Food and Drug Authority (Badan Pengawas Obat dan Makanan, BPOM) oversees the ADR reporting system, which plays a key role in ensuring drug safety and efficacy. This article explores the ADR reporting system in Indonesia, its processes, significance, challenges, and recent advancements. Visit pafikotaargamakmur.org.

The Importance of ADR Reporting

Ensuring Drug Safety

ADR reporting is essential for detecting and managing adverse effects of drugs that may not have been identified during clinical trials. These reactions can range from mild to severe and can significantly impact patient safety. By collecting and analyzing ADR reports, BPOM can identify potential risks associated with drugs and take necessary actions to mitigate them.

Improving Drug Efficacy

Understanding ADRs helps in evaluating the overall efficacy of a drug. It … READ MORE ...